Advances in the Pharmacological Management of Pediatric Acute Respiratory Distress Syndrome

References

• Ranieri VM, Rubenfeld GD, Thompson BT, et al.; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–2533.
   PubMed Web of Science ®Google Scholar
• Khemani RG, Smith LS, Zimmerman JJ, et al. Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the pediatric acute lung injury consensus conference. Pediatr Crit Care Med. 2015 16(5 Suppl 1):S23–40.
   PubMed Web of Science ®Google Scholar
• Hough RF. Recent advances in pediatric acute respiratory distress syndrome (PARDS). Curr Pediatr Rep. 2017;5(4):228–236.
   Google Scholar
• Khemani RG, Smith L, Lopez-Fernandez YM, et al., Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study. Lancet Respir Med. 7(2): 115–128. 2019.
   PubMed Web of Science ®Google Scholar
• Young M, DiSilvio B, Rao S, et al. Mechanical ventilation in ARDS. Crit Care Nurs Q. 2019;42(4):392–399.
   PubMed Web of Science ®Google Scholar
• Matera MG, Rogliani P, Bianco A, et al. Pharmacological management of adult patients with acute respiratory distress syndrome. Expert Opin Pharmacother. 2020;21(17):2169–2183.
   PubMed Web of Science ®Google Scholar
• Villar J, Kacmarek RM, Guérin C. Clinical trials in patients with the acute respiratory distress syndrome: burn after reading. Intensive Care Med. 2014;40(6):900–902.
   PubMed Web of Science ®Google Scholar
• Orloff KE, Turner DA, Rehder KJ. The current state of pediatric acute respiratory distress syndrome. Pediatr Allergy Immunol Pulmonol. 2019;32(2):35–44.
   PubMed Web of Science ®Google Scholar
• Hon KL, Leung KKY, Oberender F, et al. Paediatrics: how to manage acute respiratory distress syndrome. Drugs Context. 2021;10:1–9.
   Google Scholar
• Rowan CM, Klein MJ, Hsing DD, et al., Early use of adjunctive therapies for pediatric acute respiratory distress syndrome: a PARDIE study. Am J Respir Crit Care Med. 201(11): 1389–1397. 2020.
   PubMed Web of Science ®Google Scholar
• Villar J, Ferrando C, Martinez D, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267–276.
   PubMed Web of Science ®Google Scholar
• Meduri GU, Siemieniuk RAC, Ness RA, et al. Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS. J Intensive Care. 2018;6(1):53.
   PubMedGoogle Scholar
• Cheifetz IM. Pediatric ARDS. Respir Care. 2017;62(6):718–731.
   PubMed Web of Science ®Google Scholar
• Drago BB, Kimura D, Rovnaghi CR, et al. Double-blind, placebo-controlled pilot randomized trial of methylprednisolone infusion in pediatric acute respiratory distress syndrome. Pediatr Crit Care Med. 2015;16(3):e74–81.
   PubMedGoogle Scholar
• Yehya N, Servaes S, Thomas NJ, et al. Corticosteroid exposure in pediatric acute respiratory distress syndrome. Intensive Care Med. 2015;41(9):1658–1666.
   PubMed Web of Science ®Google Scholar
• Mitting RB, Ray S, Raffles M, et al., Improved oxygenation following methylprednisolone therapy and survival in paediatric acute respiratory distress syndrome. PLoS One. 14(11): e0225737. 2019.
   PubMed Web of Science ®Google Scholar
• Monteverde-Fernández N, Cristiani F, McArthur J, et al. Steroids in pediatric acute respiratory distress syndrome. Ann Transl Med. 2019;7(19):508.
   PubMed Web of Science ®Google Scholar
• Hartmann SM, Hough CL. Argument against the routine use of steroids for pediatric Acute respiratory distress syndrome. Front Pediatr. 2016;4:79.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Navarese EP, Zheng B, et al. Analytics with artificial intelligence to advance the treatment of acute respiratory distress syndrome. J Evid Based Med. 2020;13(4):301–312.
   PubMedGoogle Scholar
• Yu B, Ichinose F, Bloch DB, et al. Inhaled nitric oxide. Br J Pharmacol. 2019;176(2):246–255.
   PubMed Web of Science ®Google Scholar
• Tamburro RF, Kneyber MC. Pulmonary specific ancillary treatment for pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med. 2015; 16(5 Suppl 1):S61–72.
   PubMed Web of Science ®Google Scholar
• Gebistorf F, Karam O, Wetterslev J, et al. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. Cochrane Database Syst Rev. 2016;2016(6):CD002787.
   Google Scholar
• Beardsley AL. Ancillary pulmonary treatments for pediatric acute respiratory distress syndrome. In: Shein SL, Rotta AT, editors. Pediatric acute respiratory distress syndrome. Cham Switzerland: Springer Nature Switzerland AG; 2020. p. 117–126.
   Google Scholar
• Day RW, Allen EM, Witte MK. A randomized, controlled study of the 1-hour and 24-hour effects of inhaled nitric oxide therapy in children with acute hypoxemic respiratory failure. Chest. 1997;112(5):1324–1331.
   PubMed Web of Science ®Google Scholar
• Dobyns EL, Cornfield DN, Anas NG, et al. Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. J Pediatr. 1999;134(4):406–412.
   PubMed Web of Science ®Google Scholar
• Ibrahim TS, El-Mohamady HS. Inhaled nitric oxide and prone position: how far they can improve oxygenation in pediatric patients with acute respiratory distress syndrome? J Med Sci. 2007;7(3):390–395.
   Google Scholar
• Afshari A, Brok J, Møller AM, et al. Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children: a systematic review with meta-analysis and trial sequential analysis. Anesth Analg. 2011;112(6):1411–1421.
   PubMed Web of Science ®Google Scholar
• Bhalla AK, Yehya N, Mack WJ, et al. The association between inhaled nitric oxide treatment and ICU mortality and 28-day ventilator-free days in pediatric acute respiratory distress syndrome. Crit Care Med. 2018;46(11):1803–1810.
   PubMed Web of Science ®Google Scholar
• Dowell JC, Thomas NJ, Yehya N. Association of response to inhaled nitric oxide and duration of mechanical ventilation in pediatric acute respiratory distress syndrome. Pediatr Crit Care Med. 2017;18(11):1019–1026.
   PubMed Web of Science ®Google Scholar
• Berger JT, Maddux AB, Reeder RW, et al., Inhaled nitric oxide use in pediatric hypoxemic respiratory failure. Pediatr Crit Care Med. 21(8): 708–719.ù. 2020.
   Web of Science ®Google Scholar
• Bronicki RA, Fortenberry J, Schreiber M, et al. Multicenter randomized controlled trial of inhaled nitric oxide for pediatric acute respiratory distress syndrome. J Pediatr. 2015;166(2):365–369.
   PubMed Web of Science ®Google Scholar
• Macrae DJ, Field D, Mercier JC, et al. Inhaled nitric oxide therapy in neonates and children: reaching a European consensus. Intensive Care Med. 2004;30(3):372–380.
   PubMed Web of Science ®Google Scholar
• Fortenberry JD. When do we say “No” to iNO? Pediatr Crit Care Med. 2017;18(11):1065–1066.
   PubMed Web of Science ®Google Scholar
• Tang SF, Sherwood MC, Miller OI. Randomised trial of three doses of inhaled nitric oxide in acute respiratory distress syndrome. Arch Dis Child. 1998;79(5):415–418.
   PubMed Web of Science ®Google Scholar
• Thomas CA, Valentine K. Utility of routine methemoglobin laboratory assays in critically ill pediatric subjects receiving inhaled nitric oxide. J Crit Care. 2018;48:63–65.
   PubMed Web of Science ®Google Scholar
• Pappert D, Busch T, Gerlach H, et al. Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome. Anesthesiology. 1995;82(6):1507–1511.
   PubMed Web of Science ®Google Scholar
• Dahlem P, van Aalderen WM, de Neef M, et al. Randomized controlled trial of aerosolized prostacyclin therapy in children with acute lung injury. Crit Care Med. 2004;32(4):1055–1060.
   PubMed Web of Science ®Google Scholar
• Siddiqui S, Zubair S, Khan FH. Case of inhaled prostaglandin E1 used to improve hypoxia in ARDS. J Pak Med Assoc. 2004;54(12):635–636.
   PubMedGoogle Scholar
• Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. N Engl J Med. 2017;377(6):562–572.
   PubMed Web of Science ®Google Scholar
• Meng SS, Chang W, Lu ZH, et al. Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials. BMC Pulm Med. 2019;19(1):9.
   PubMedGoogle Scholar
• Willson DF, Jiao JH, Bauman LA, et al. Calf’s lung surfactant extract in acute hypoxemic respiratory failure in children. Crit Care Med. 1996;24(8):1316–1322.
   PubMed Web of Science ®Google Scholar
• Willson DF, Zaritsky A, Bauman LA, et al. Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure. Members of the Mid-Atlantic pediatric critical care network. Crit Care Med. 1999;27(1):188–195.
   PubMed Web of Science ®Google Scholar
• Willson DF, Thomas NJ, Markovitz BP, et al. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA. 2005;293(4):470–476.
   PubMed Web of Science ®Google Scholar
• Willson DF, Thomas NJ, Tamburro R, et al. Pediatric calfactant in acute respiratory distress syndrome trial. Pediatr Crit Care Med. 2013;14(7):657–665.
   PubMed Web of Science ®Google Scholar
• Thomas NJ, Spear D, Wasserman E, et al. CALIPSO: a randomized controlled trial of calfactant for acute lung injury in pediatric stem cell and oncology patients. Biol Blood Marrow Transplant. 2018;24(12):2479–2486.
   PubMed Web of Science ®Google Scholar
• Möller JC, Schaible T, Roll C, et al. Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study. Intensive Care Med. 2003;29(3):437–446.
   PubMed Web of Science ®Google Scholar
• Luchetti M, Casiraghi G, Valsecchi R, et al. Porcine-derived surfactant treatment of severe bronchiolitis. Acta Anaesthesiol Scand. 1998;42(7):805–810.
   PubMed Web of Science ®Google Scholar
• Luchetti M, Ferrero F, Gallini C, et al. Multicenter, randomized, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure. Pediatr Crit Care Med. 2002;3(3):261–268.
   PubMedGoogle Scholar
• Wolfler A, Piastra M, Amigoni A, et al., A shared protocol for porcine surfactant use in pediatric acute respiratory distress syndrome: a feasibility study. BMC Pediatr. 19(1): 203. 2019.
   PubMedGoogle Scholar
• De Luca D, Piastra M, Chidini G, et al. The use of the Berlin definition for acute respiratory distress syndrome during infancy and early childhood: multicenter evaluation and expert consensus. Intensive Care Med. 2013;39(12):2083–2091.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Moya VS, Gallo-Borrero CM, Santos-Arias D, et al. Exogenous surfactant and alveolar recruitment in the treatment of the acute respiratory distress syndrome. Clin Respir J. 2017;11(6):1032–1039.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Moya VS, Machado-Lubián MC, Barrese-Pérez Y, et al. Cuban exogenous pulmonary surfactant in treatment of pediatric acute respiratory distress syndrome. MEDICC Rev. 2017;19(2–3):24–31.
   PubMed Web of Science ®Google Scholar
• Tridente A, De Martino L, De Luca D. Porcine vs bovine surfactant therapy for preterm neonates with RDS: systematic review with biological plausibility and pragmatic meta-analysis of respiratory outcomes. Respir Res. 2019;20(1):28.
   PubMedGoogle Scholar
• Thomas NJ, Guardia CG, Moya FR, et al. A pilot, randomized, controlled clinical trial of lucinactant, a peptide-containing synthetic surfactant, in infants with acute hypoxemic respiratory failure. Pediatr Crit Care Med. 2012;13(6):646–653.
   PubMed Web of Science ®Google Scholar
• Ho ATN, Patolia S, Guervilly C. Neuromuscular blockade in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. J Intensive Care. 2020;8(1):12.
   PubMed Web of Science ®Google Scholar
• Moss M, Huang DT, Brower RG, et al.; National Heart, Lung, and Blood Institute PETAL Clinical Trials Network. Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med 2019;380(21):1997–2008.
   PubMed Web of Science ®Google Scholar
• Da Silva PS, Neto HM, de Aguiar VE, et al. Impact of sustained neuromuscular blockade on outcome of mechanically ventilated children. Pediatr Int. 2010;52(3):438–443.
   PubMed Web of Science ®Google Scholar
• Wilsterman MEF, de Jager P, Blokpoel R, et al. Short-term effects of neuromuscular blockade on global and regional lung mechanics, oxygenation and ventilation in pediatric acute hypoxemic respiratory failure. Ann Intensive Care. 2016;6(1):103.
   PubMedGoogle Scholar
• Chandra S, Goel S, Dawra R. Early neuromuscular blockade in children with pediatric acute respiratory distress syndrome. J Pediatr Intensive Care. 2020;9(3):201–206.
   PubMedGoogle Scholar
• Ponnarmeni S, Kumar Angurana S, Singhi S, et al. Vitamin D deficiency in critically ill children with sepsis. Paediatr Int Child Health. 2016;36(1):15–21.
   PubMed Web of Science ®Google Scholar
• McNally JD, Nama N, O’Hearn K, et al. Vitamin D deficiency in critically ill children: a systematic review and meta-analysis. Crit Care. 2017;21(1):287.
   PubMedGoogle Scholar
• Cariolou M, Cupp MA, Evangelou E, et al. Importance of vitamin D in acute and critically ill children with subgroup analyses of sepsis and respiratory tract infections: a systematic review and meta-analysis. BMJ Open. 2019;9(5):e027666.
   PubMed Web of Science ®Google Scholar
• He M, Cao T, Wang J, et al. Vitamin D deficiency relation to sepsis, paediatric risk of mortality III score, need for ventilation support, length of hospital stay, and duration of mechanical ventilation in critically ill children: a meta-analysis. Int J Clin Pract. 2021;75(4):e13908.
   PubMed Web of Science ®Google Scholar
• Das S, Biswal MKK, Parameswaran N, et al., Association between vitamin D deficiency and duration of hospital stay, pediatric intensive care unit stay, and ventilation; pediatric risk of mortality score; and rate of readmission: a prospective observational study. Cureus. 12(9): e10322. 2020.
   PubMed Web of Science ®Google Scholar
• Desai MH, Mlcak R, Richardson J, et al. Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin/N-acetylcystine [correction of acetylcystine] therapy. J Burn Care Rehabil. 1998;19(3):210–212.
   PubMedGoogle Scholar
• Navas-Blanco JR, Dudaryk R. Management of respiratory distress syndrome due to COVID-19 infection. BMC Anesthesiol. 2020;20(1):177.
   PubMed Web of Science ®Google Scholar
• Matera MG, Rogliani P, Calzetta L, et al. Pharmacological management of COVID-19 patients with ARDS (CARDS): a narrative review. Respir Med. 2020;171:106114.
   PubMed Web of Science ®Google Scholar
• Rajapakse N, Dixit D. Human and novel coronavirus infections in children: a review. Paediatr Int Child Health. 2021;41(1):36–55.
   PubMed Web of Science ®Google Scholar
• Galindo R, Chow H, Rongkavilit C. COVID-19 in children: clinical manifestations and pharmacological interventions including vaccine trials. Pediatr Clin North Am. 2021;68(5):961–976.
   PubMed Web of Science ®Google Scholar
• Hong YN, Xu J, Sasa GBK, et al. Remdesivir as a broad-spectrum antiviral drug against COVID-19. Eur Rev Med Pharmacol Sci. 2021;25(1):541–548.
   PubMed Web of Science ®Google Scholar
• Méndez-Echevarría A, Pérez-Martínez A, Gonzalez Del Valle L, et al. Compassionate use of remdesivir in children with COVID-19. Eur J Pediatr. 2021;180(4):1317–1322.
   PubMed Web of Science ®Google Scholar
• Goldman DL, Aldrich ML, Hagmann SHF, et al. Compassionate use of remdesivir in children with severe COVID-19. Pediatrics. 2021;147(5):e2020047803.
   PubMed Web of Science ®Google Scholar
• Chiotos K, Hayes M, Kimberlin DW, et al., Multicenter interim guidance on use of antivirals for children with Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2. J Pediatric Infect Dis Soc. 10(1): 34–48. 2021.
   PubMed Web of Science ®Google Scholar
• NIH. COVID-19 Treatment Guidelines. Special considerations in children. Available at: https://www.covid19treatmentguidelines.nih.gov/special-populations/children/. Last access 2021 Jul 13.
   Google Scholar
• Horby P, Lim WS, Emberson JR, et al.; RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021; 384(8):693–704.
   PubMed Web of Science ®Google Scholar
• Parisi GF, Indolfi C, Decimo F, et al. COVID-19 pneumonia in children: from etiology to management. Front Pediatr. 2020;8:616622.
   PubMed Web of Science ®Google Scholar
• Kneyber MCJ, Medina A, Modesto I Alapont V, et al. Practice recommendations for the management of children with suspected or proven COVID-19 infections from the Paediatric Mechanical Ventilation Consensus Conference (PEMVECC) and the section Respiratory Failure from the European Society for Paediatric and Neonatal Intensive Care (ESPNIC). Available at: https://scp.com.co/wp-content/uploads/2020/04/2020-ESPNIC-PEMVECC-COVID-19-practice-recommendations.pdf.pdf. Last access 2021 Jul 15.
   Google Scholar
• FDA News Release. Coronavirus (COVID-19) update: FDA authorizes monoclonal antibodies for treatment of COVID-19. Available at: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19. Last access 2021 Jul 13.
   Google Scholar
• FDA. Emergency Use Authorization 094. Available at: https://www.fda.gov/media/145801/download. Last access 2021 Jul 13.
   Google Scholar
• Yılmaz K, Şen V. Is vitamin D deficiency a risk factor for COVID-19 in children? Pediatr Pulmonol. 2020;55(12):3595–3601.
   PubMed Web of Science ®Google Scholar
• NICE. COVID-19 rapid guideline: vitamin D. Available at: https://www.nice.org.uk/guidance/ng187/chapter/Recommendations. 2021 Jul 14.
   Google Scholar
• Smith LS, Zimmerman JJ, Martin TR. Mechanisms of acute respiratory distress syndrome in children and adults: a review and suggestions for future research. Pediatr Crit Care Med. 2013;14(6):631–643.
   PubMed Web of Science ®Google Scholar
• Matthay MA, Zemans RL, Zimmerman GA, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019;5(1):18.
   PubMed Web of Science ®Google Scholar
• Meduri GU, Marik PE, Chrousos GP, et al. Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med. 2008;34(1):61–69.
   PubMed Web of Science ®Google Scholar
• Schwingshackl A, Meduri GU. Rationale for prolonged glucocorticoid use in pediatric ARDS: what the adults can teach us. Front Pediatr. 2016;4:58.
   PubMed Web of Science ®Google Scholar
• Williams DM. Clinical pharmacology of corticosteroids. Respir Care. 2018;63(6):655–670.
   PubMed Web of Science ®Google Scholar
• Amigoni A, Pettenazzo A, Stritoni V, et al. Surfactants in acute respiratory distress syndrome in infants and children: past, present and future. Clin Drug Investig. 2017;37(8):729–736.
   PubMed Web of Science ®Google Scholar
• De Luca D, Cogo P, Kneyber MC, et al., Surfactant therapies for pediatric and neonatal ARDS: ESPNIC expert consensus opinion for future research steps. Crit Care. 25(1): 75. 2021.
   PubMed Web of Science ®Google Scholar